PolyPeptide Group AG (XSWX:PPGN) Operating Cash Flow per Share : CHF0.99 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Operating Cash Flow per Share?

PolyPeptide Group AG's operating cash flow per share for the six months ended in Dec. 2023 was CHF2.42. PolyPeptide Group AG's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.99.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of PolyPeptide Group AG was 540.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -16.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for PolyPeptide Group AG's Operating Cash Flow per Share or its related term are showing as below:

XSWX:PPGN' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -56.8 Med: -16.3 Max: 29.1
Current: -16.3

During the past 6 years, PolyPeptide Group AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 29.10% per year. The lowest was -56.80% per year. And the median was -16.30% per year.

XSWX:PPGN's 3-Year OCF Growth Rate is ranked worse than
78.4% of 801 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs XSWX:PPGN: -16.30

PolyPeptide Group AG Operating Cash Flow per Share Historical Data

The historical data trend for PolyPeptide Group AG's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Operating Cash Flow per Share Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

2.02

1.78

1.86

0.16

1.04

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial					0.51	-0.24	0.39	-1.43	2.42

Competitive Comparison of PolyPeptide Group AG's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, PolyPeptide Group AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PolyPeptide Group AG's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PolyPeptide Group AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PolyPeptide Group AG's Price-to-Operating-Cash-Flow falls into.

PolyPeptide Group AG Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

PolyPeptide Group AG's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	34.408	/	32.968
	=	1.04

PolyPeptide Group AG's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	79.979	/	32.988
	=	2.42

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.99

PolyPeptide Group AG Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines